The Effects of Low Flow and Normal Flow Desflurane Anesthesia
1 other identifier
interventional
60
1 country
1
Brief Summary
Aging is a physiological process. In the elderly, loss of functional reserve in all organ system, regression in anabolic processes and increase in catabolic processes are observed s (1). The number of geriatric patients is also increasing in our country. Technological developments in anesthesia and surgery technics show that we will provide medical services to more elderly patients over time(2). Cystatin C is excreted only by the kidney (7, 8). Serum cystatin C level is not affected by body muscle mass, age and gender. The half-life is short. Because of all these features, it is thought to be more sensitive than creatinine in evaluating kidney functions (8,9). In this study, it was aimed to compare the effects of low flow and normal flow desflurane anesthesia applied in geriatric patients on postoperative liver and kidney functions and serum cystatin C levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2022
CompletedFirst Submitted
Initial submission to the registry
May 24, 2022
CompletedFirst Posted
Study publicly available on registry
June 10, 2022
CompletedJune 10, 2022
June 1, 2022
8 months
May 24, 2022
June 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Alanin Aminotransferaz (ALT)
To research the serum alanin Aminotransferaz (ALT) , blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
24 hours
Aspartat Aminotransferaz (AST)
To research the serum Aspartat Aminotransferaz (AST) , blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
24 hours
Serum creatinine
To research the serum creatinine , blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
24 hours
Serum cystatin C
To research the Serum cystatin C , blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
24 hours
Blood urea nitrogen (BUN)
To research the Blood urea nitrogen (BUN) , blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
24 hours
Secondary Outcomes (8)
Heart rate (HR)
6 hours
Systolic blood pressure (SBP)
6 hours
Diastolic blood pressure (DBP)
6 hours
Mean blood pressure (MBP)
6 hours
Drug allergies
24 hours
- +3 more secondary outcomes
Study Arms (2)
Low flow desflurane anesthesia (Group D)
ACTIVE COMPARATORAll patients were preoxygenated for three minutes. Midazolam 0.03 mg/kg, fentanyl 1.5 mcg/kg , propofol 2 mg/kg and rocuronium 0.6 mg/kg were administered iv for induction of anesthesia. After intubation all patients were mechanically ventilated with 50% O2+50% air + 6-7% desflurane in a 4 L/min fresh gas flow until the MAC value reached 1. When the MAC value of desflurane was 1, fresh gas flow was decreased to 0.5 L/min (60% O2+40% air) in Group D. Hemodynamic parameters, SpO2 and BIS values were recorded after induction, at the beginning of low flow/normal flow anesthesia and every 5 minutes during surgery. The patients were observed in terms of side effects and complications during the operation and in the postoperative period. To research the liver and the kidney functions, blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
Normal flow desflurane anesthesia (Group N)
NO INTERVENTIONAll patients were preoxygenated for three minutes. Midazolam 0.03 mg/kg, fentanyl 1.5 mcg/kg , propofol 2 mg/kg and rocuronium 0.6 mg/kg were administered iv for induction of anesthesia. After intubation all patients were mechanically ventilated with 50% O2+50% air + 6-7% desflurane in a 4 L/min fresh gas flow until the MAC value reached 1. When the MAC value of desflurane was 1, fresh gas flow was decreased to 2 L/min (40% O2+60% air) in Group N. Hemodynamic parameters, SpO2 and BIS values were recorded after induction, at the beginning of low flow/normal flow anesthesia and every 5 minutes during surgery. The patients were observed in terms of side effects and complications during the operation and in the postoperative period. To research the liver and the kidney functions, blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
Interventions
When the MAC value of desflurane was 1, fresh gas flow was decreased to 0.5 L/min (60% O2+40% air). Hemodynamic parameters, SpO2 and BIS values were recorded after induction, at the beginning of low flow/normal flow anesthesia and every 5 minutes during surgery. The patients were observed in terms of side effects and complications during the operation and in the postoperative period. To research the liver and the kidney functions, blood samples were taken pre-induction, post-surgery, and at the postoperative 24th hour by venous route.
Eligibility Criteria
You may qualify if:
- Patients with an American Society of Anesthesiologists (ASA) status of class I-III,
- Aged between 65 and 100 years,
- Scheduled to undergo general anesthesia and, the surgeries that will take longer than 1 hour.
You may not qualify if:
- ASA class ≥ III patients
- Thorasic surgery
- Neurosurgery
- Cardiorespiratory disease,
- Uncontrolled diabetes mellitus,
- Coagulation disorders,
- Preoperative liver and renal dysfunction,
- History of malignant hyperthermia,
- Using nephrotoxic or hepatotoxic drugs,
- Major bleeding (\>1000 cc) is predicted in the operation,
- Chronic alcoholism,
- Patients with drug use or withdrawal symptoms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van Yüzüncü Yıl University, Faculty of Medicine
Van, Tusba, 65080, Turkey (Türkiye)
Related Publications (3)
Horwitz M, Jakobsson JG. Desflurane and sevoflurane use during low- and minimal-flow anesthesia at fixed vaporizer settings. Minerva Anestesiol. 2016 Feb;82(2):180-5. Epub 2015 Jul 22.
PMID: 26198766BACKGROUNDXie G, Jiang H. Clinical study of desflurane on low flow anesthesia compared with sevoflurane and enflurane. Chin Med J (Engl). 1997 Sep;110(9):707-10.
PMID: 9642331BACKGROUNDBaum JA, Aitkenhead AR. Low-flow anaesthesia. Anaesthesia. 1995 Oct;50 Suppl:37-44. doi: 10.1111/j.1365-2044.1995.tb06189.x.
PMID: 7485917BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Hacı Yusuf YG Güneş, Assist.prof
Van Yüzüncü Yıl University Van, Turkey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant proffesor
Study Record Dates
First Submitted
May 24, 2022
First Posted
June 10, 2022
Study Start
May 28, 2021
Primary Completion
January 28, 2022
Study Completion
March 30, 2022
Last Updated
June 10, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- 6 months
- Access Criteria
- The access can be provided via the e-mail addresses below hyusufgunes@hotmail.com
Study protocol and statistical analysis plan will be share for other resarchers.